Addison's disease in dogs and pet insurance: a lifelong hormone bill, a crisis invoice and the breed clauses

Two missing hormones, two lines on every invoice

Addison's disease, or hypoadrenocorticism, is the adrenal glands failing to make enough of two hormone types. Merck describes it as mineralocorticoid and glucocorticoid deficiency. The mineralocorticoid, aldosterone, holds sodium and lets the body shed potassium; the glucocorticoid, cortisol, carries the dog through illness and stress. Cornell adds that some dogs have an "atypical" form in which only cortisol is affected and the electrolytes stay normal, and Merck notes that atypical cases can later progress to the full deficiency. Which form a dog has, and which drugs suit it, is a veterinarian's decision. What follows reads the bills and the policy wording around that treatment, with no insurer ranked or recommended.

The two hormones become two separate cost lines. Cornell's treatment summary is that cortisol is replaced with a daily oral steroid such as prednisone, while aldosterone is replaced with an injection such as Percorten or Zycortal "about once per month," or with an oral drug, Florinef (fludrocortisone), that covers both. Merck's nonemergency treatment section lists the same two routes: desoxycorticosterone pivalate (DOCP) plus prednisone, or fludrocortisone, with prednisone added for some dogs. Merck also says treatment "is often needed throughout the life of the patient" and carries an excellent long-term prognosis.

That combination is what makes Addison's an unusual insurance file. The claim usually starts young: Merck puts onset mostly in young to middle-aged adults, and Cornell says the same, adding that females may be at increased risk. So a dog diagnosed at four or five can generate a hormone bill for many renewals, in an age band where the premium has not yet climbed the way it does for a ten-year-old. The disease is also hard to spot. Both Merck and Cornell call it a great imitator or pretender, because the early signs wax and wane and look like ordinary stomach upsets. That detail matters later, when an insurer reads the medical record to find the date of the first sign.

Zycortal, Percorten-V and a human tablet: the schedule each one sets

Two DOCP products appear on DailyMed, the National Library of Medicine's label database, as checked October 31, 2026: Zycortal (Dechra, FDA NADA 141-444), given under the skin, and Percorten-V (Elanco, NADA 141-029), given into the muscle, whose label was republished in August 2026. Both come as 4 mL vials holding 25 mg per mL, so 100 mg a vial. Fludrocortisone has no veterinary label: all 18 fludrocortisone entries on DailyMed are 0.1 mg tablets made for people, indicated as partial replacement therapy for adrenocortical insufficiency in Addison's disease. The FDA's page on the Animal Medicinal Drug Use Clarification Act explains that veterinarians may prescribe approved human drugs for animals as extralabel use, within a veterinarian-client-patient relationship.

The labels read like a visit schedule. The table sets out what each one says about dose and monitoring; dose choices for a particular dog remain with the veterinarian.

Zycortal's field study is the best public guide to what long-term dosing looks like. Of 152 dogs aged 0.5 to 12.4 years, 113 received Zycortal; treatment success was 86.2 percent at day 90 and 88.3 percent at day 180, and the mean final dose was 1.9 mg/kg, with most dogs dosed every 20 to 46 days. The Zycortal label also tells the veterinarian to consider a temporary increase in the prednisone or prednisolone dose before a stressful situation, which is why a boarding stay or a surgery for something unrelated can add a recheck visit to an Addison's year.

From label doses to a year's quantities for two dog sizes

Drug quantity follows body weight, and the vial rule changes the arithmetic for small dogs. The table converts the label and Merck doses into yearly amounts for a 55-pound (25 kg) dog, inside the Standard Poodle's 40 to 70 pound range on its breed page, and a 15-pound (6.8 kg) terrier the size of a Westie. The weights and the 25-day interval are illustration inputs, not predictions for any dog.

Two points come out of the table. First, the small dog's DOCP use is not proportional to its weight. Its 15 mg dose would stretch one 100 mg vial over more than six injections, but the Zycortal label's 120-day limit after first puncture stops it at five, so a quarter of every vial is thrown away. Second, fludrocortisone is a tablet count, not an injection schedule, and for a 55-pound dog the Merck starting dose is five tablets every day. Where a pharmacy price per tablet is known, the yearly cost is that price times 1,825. Both facts carry straight into the claim, because a policy reimburses what was bought and dispensed, including the unused part of a vial a clinic charges for.

The same bills against four annual limit designs

A lifelong condition tests the annual limit twice: once in the expensive first year, and again every year after, because the limit resets but the disease does not. The table runs the DOCP route's two totals through four designs. Designs 1 to 3 are illustrations. Design 4 uses a real number from an older form: Nationwide's Veterinary Pet Insurance Major Medical Plan, California edition VS-G-3-CA (02-15), prints Addison's disease as diagnosis code 2902 with a Column A primary allowance of $945 and a Column B secondary allowance of $395. That form says its diagnosis allowances "are the most that we will pay during the policy term for any condition covered by this policy, regardless of the number of incidents or treatments."

Without a crisis, the $5,000 limit in Design 1 is never reached, even in year one. The bigger losses come from the other two lines. Exam fees matter because Addison's monitoring is mostly visits: three of the five sample forms exclude the exam fee. The AKC Pet Insurance North Carolina sample excludes "Physical examination" unless the owner buys its optional ExamPlus coverage, Figo's sample excludes it unless Optional Office Visit and Exam Fees Coverage is on the declarations page, and Trupanion's 2011 policy form lists "Veterinary examination fees" first among its general exclusions. The Spot Arizona sample, by contrast, defines covered treatment to include "consultations, examinations" and laboratory tests. The exam fee guide explains why that one clause shifts so much of a chronic claim.

The schedule form shows the other risk. A per-condition allowance that resets each term but never grows turns a lifelong disease into a fixed $945 contribution against bills that, in this illustration, run three to six times higher. That edition is old and was filed for California, and it says nothing about what Nationwide sells now. It is here because it shows that a cap can apply per condition rather than per year. The limits decoder explains the other per-condition and per-incident caps that appear on declarations pages.

Over many years the later-year line is the one that counts. Nine later years at the illustration's $2,846 come to $25,614 of bills, a simple multiplication shown for scale, not a forecast. Under Design 1 the owner's share of those nine years is $8,722.80, under Design 2 it is $4,586.40, and under Design 4 it is at least $17,109. For a Standard Poodle the published premium anchor is $75 per month (AdvisorSmith published premium research, reviewed October 4, 2026), a published anchor and not a quote, and premiums rise with age, as the premium increase guide explains. Generic deductible and percentage arithmetic for your own quote can be checked on CalculatorVillage.

When the crisis is the first sign: waiting periods and the earlier stomach upsets

Addison's often reaches a diagnosis by surprise, and that is where most claim disputes begin. A crisis in the first weeks of a new policy is a waiting-period question. The Spot sample says "Any condition that occurs during an applicable waiting period is a pre-existing condition," and the Figo sample defines pre-existing to include "a Chronic Condition observed by You or Your Veterinary Provider prior to the Original Start Date or prior to the end of the Waiting Period for Your Pet and any related conditions." Figo defines a chronic condition as one "deemed incurable or likely to continue for the remainder of Your Pet's life," which fits Addison's as Merck describes it. A crisis one day inside the waiting period can therefore shut out not just that invoice but every injection afterwards. The waiting period guide lists typical lengths.

The harder case is a dog with no crisis but a history of mild, vague visits. Because Addison's signs "can wax and wane, or be vague and non-specific," in Cornell's words, a chart from before the policy may show a visit for vomiting, a day of diarrhea, or a note that the dog was lethargic. Spot dates a condition from when signs "first were observed by any individual, recorded in your pet's medical record, or would have been detectable by a routine physical veterinary exam," and counts conditions "related to, secondary, or resultant from" a pre-existing one. An insurer reviewing a later Addison's diagnosis may go back to that note and ask whether it was the first sign. Some will decide it was an unrelated stomach upset; others will not. An owner cannot rewrite the chart, but can make sure the record shows how each episode resolved. The vomiting and diarrhea guide covers how those visits are read.

The "cured" rules that rescue some old conditions do not help here. Spot treats a curable pre-existing condition as new after 180 days free of treatment and symptoms, but "This does not apply to chronic conditions"; Figo's 12-month cured rule requires the condition to be curable in the first place. A disease treated for life never meets either test. One sample goes the other way: the AKC North Carolina form lists "Pre-existing Conditions after a three hundred and sixty-five (365) day Waiting Period" among covered items, with that waiting period waived at renewal only for continuous cover. That is unusual wording in a single-state sample, not a market norm, and the pre-existing conditions decoder explains how look-backs and waiting periods differ across forms.

Breeds Merck and Cornell name, and the Standard Poodle numbers

Merck notes that mixed-breed dogs are diagnosed most often, which is a reminder that a breed list describes overrepresentation, not certainty. The two references overlap on five breeds. The table sets them side by side, with the site's published premium anchor where a breed page exists (anchors reviewed October 4, 2026, published research, not quotes).

The Standard Poodle row is the only one on the site with a breed-specific measurement. Famula and colleagues enrolled 778 Standard Poodles with known status, confirmed by ACTH challenge, and classed 8.6 percent as Addisonian. They found both sexes equally likely to be affected, estimated heritability at 0.75, and their segregation analysis suggested the disease "is influenced by an autosomal recessive locus." The authors' own word choice, influenced rather than determined, becomes important in the next section. The 8.6 percent comes from a research cohort, not a census of the breed. Even so, it is the reason the Standard Poodle page puts Addison's first on its coverage checklist. Labradoodle owners inherit part of the question through the Poodle parent, which the Labradoodle page discusses with its own survey figures.

For an insurer, a breed list does two things. It can feed the premium, since breed is a rating factor; Trupanion's 2011 form, for example, names breed among the enrollment factors that set the monthly premium. And it gives a claims reviewer a reason to look harder at the hereditary wording. Neither changes the core test, which is still the date of the first sign against the start date and the waiting period.

Inherited by whose definition? Five sample forms read against Addison's

Two of the five sample forms define an inherited or genetic condition, and both use the same verb. AKC's sample says "Inherited means an Illness, disease or condition whose presence is determined by genetic factors." Figo's says "Genetic Condition means an Illness whose presence is determined by hereditary factors." Merck states that the cause of most canine Addison's is "unknown but is suspected to be immune mediated," and Famula's result is a strong genetic influence, not a single gene that decides it. Whether a disease with a 0.75 heritability estimate has its presence "determined" by genetics is the kind of question an insurer answers, not the owner. It is worth asking before a claim, in writing.

What each form does with the definition differs, and the table shows it. These are sample or historical forms, each for one state or edition, and current policies may differ; your own policy form governs.

The table explains why the Standard Poodle question is about more than the hereditary clause. In two of these documents the inherited label does nothing, because they do not exclude it. In one it might matter, depending on an optional add-on. In another it depends on a list kept outside the contract. The hereditary and bilateral exclusions guide covers the same three definitions for orthopedic and eye disease. For Addison's the practical step is narrow: name the disease in an email and ask whether the insurer classifies it as hereditary, congenital, both or neither.

A tablet approved for people, and the medication definition

Fludrocortisone raises a separate question from DOCP, because the tablets in a dog's bottle carry a human label. Policies differ on how they define a covered drug. The Nationwide 2015 form defines drugs as medication "approved by the U.S. Food and Drug Administration (FDA) that is used to treat a condition," which a human tablet prescribed extralabel appears to satisfy. Figo's sample defines medications as those "prescribed by a Veterinarian and approved by the Food and Drug Administration (FDA) of the United States or accepted for inclusion in the Homeopathic Pharmacopoeia of the United States for veterinary use." Read one way, "for veterinary use" qualifies only the homeopathic listing; read another way, it qualifies the FDA approval too. The AKC sample's definition turns on how a drug is dispensed: "any medicine that is dispensed from a Veterinarian pharmacy or with a written prescription from a Veterinarian that may only be filled at a pharmacy."

Prednisone is in the same position, a human generic used daily by most Addison's dogs. Both DOCP products are FDA-approved veterinary drugs, so the definition question is narrower for the injection route. For a dog on fludrocortisone, the question to put in writing is short: are FDA-approved human drugs prescribed by a veterinarian and filled at a retail pharmacy reimbursed under the policy's medication benefit? A yes by email is worth more than any reading of the definition.

Addison's that follows treatment for Cushing's

Merck lists "adrenocortical enzyme inhibitors (trilostane)" and the cytotoxic drug mitotane among the other causes of adrenocortical failure. Both are drugs used for the opposite disease, Cushing's, where the adrenal glands make too much cortisol. A dog treated for Cushing's whose adrenal function then fails therefore has a second condition that a claims reviewer may call "related to, secondary, or resultant from" the first, in Spot's phrase.

If the Cushing's was covered, that link is usually harmless: the Addison's claim joins a covered condition. If the Cushing's was pre-existing, the same link can carry the exclusion across to the new diagnosis. The Cushing's disease insurance guide works through the trilostane label's quarterly ACTH stimulation tests and the renewal premium. For an owner whose dog has had both diagnoses, the question for the insurer is whether it treats the second as a new condition or as part of the first. Other lifelong conditions that raise the same renewal and related-condition questions are collected on the conditions hub.

A paper file for a predisposed breed, started while the record is clean

For a Standard Poodle, Westie, Bearded Collie, Great Dane or Portuguese Water Dog, the clauses above are cheapest to settle while the record is still clean. Each item below closes one of the gaps in the worked examples.

• The full policy form and declarations page, with the annual limit, the deductible type and any per-condition allowance marked.
• A written answer on whether Addison's disease is classed as hereditary, congenital or neither, and whether an optional hereditary add-on is needed to cover it.
• A written answer on whether exam fees at injection and electrolyte recheck visits are covered, or need an add-on.
• A written answer on whether human-labelled drugs such as fludrocortisone and prednisone, filled at an outside pharmacy, are reimbursed.
• A copy of the medical record as it stands on the policy start date, so any earlier stomach upset is documented with its outcome.
• Proof of continuous cover at every renewal, since a lapse resets the waiting period and turns a lifelong condition into a pre-existing one.

If the dog is a Standard Poodle, the Standard Poodle breed page is the next stop. It sets the Addison's figures beside the breed's bloat and sebaceous adenitis risks, which compete for the same annual limit, and it carries the premium anchor to judge a live quote against before deciding.